Evidence map›Paper›PMID 41782920›Full record

ReviewFrontiers in neuroscience2026

Deciphering the disease ecosystem of ischemic stroke via multi-omics and prospects for therapeutic strategies.

Jingwen Zhang, Jiajie Niu, Jingwen Zhao, Linjing Wang, Tuozi Wang, Shuai Shi

Abstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingwen ZhangHeilongjiang University of Chinese Medicine, Graduate School, Harbin, China.
Jiajie NiuHeilongjiang University of Chinese Medicine, Graduate School, Harbin, China.
Jingwen ZhaoHeilongjiang University of Chinese Medicine, Graduate School, Harbin, China.
Linjing WangHeilongjiang University of Chinese Medicine, Graduate School, Harbin, China.
Tuozi WangThe Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Department of Geriatrics, Harbin, Heilongjiang, China.
Shuai ShiHeilongjiang University of Chinese Medicine, Graduate School, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke (IS) remains a leading cause of disability due to the translational failure of single-target therapies, underscoring the limitations of the traditional neuron-centric view. This review proposes a paradigm shift by conceptualizing IS as a dynamically evolving "disease ecosystem." We integrate multi-omics evidence to delineate five interconnected core features-cellular identity collapse, inflammatory-reparative imbalance, neurovascular unit disintegration, brain-peripheral immune miscommunication, and extracellular matrix scarring-that form a pathological logic axis driving disease progression. Based on this systemic understanding, we advance the novel therapeutic strategy of "ecosystem engineering," which emphasizes temporally adaptive, spatially precise, and network-coordinated interventions. This framework aims to overcome current therapeutic bottlenecks and usher in a new era of precision neural repair.

Indexed as

brain-peripheral immune axiscellular identity collapsedisease ecosystemischemic cerebral infarctionneurovascular unit

Identifiers

PMID41782920
PMCPMC12953568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.